银诺医药-B(02591)及银诺技术合共认购1.25亿元宁波银行结构性存款产品

Group 1 - The company, Silver诺医药-B (02591), announced that on December 1, 2025, it, along with its wholly-owned subsidiary Silver诺技术, will subscribe to a structured deposit product from 宁波银行 for a total consideration of RMB 125 million, which is equivalent to its total principal amount [1]